Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
BACKGROUND: Although the eradication of Helicobacter pylori is of primary importance when initiating treatment, it is also important to have a strategy for patients who are H pylori-negative, fail to demonstrate eradication or have a tendency to become re-infected or relapse.
Saved in:
Main Authors: | K Lauritsen, K Rutgersson, E Bolling, G Brunner, S Eriksson, JP Galmiche, A Walan, AP Archambault, H Gudjónsson, RJ Bailey, G Bianchi Porro, L Frison, N Havu, ABR Thompson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1999-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1999/395876 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ranitidine bismuth citrate: A review
by: N Chiba, et al.
Published: (2001-01-01) -
The Equivalence of Two Open Therapeutic Regimens of Cimetidine in the Treatment of Acute Duodenal Ulcer Disease: A Canadian Multicentre Trial
by: H Navert, et al.
Published: (1990-01-01) -
Omeprazole: Inhibiting the Final Common Pathway to Acid Secretion - The Acid Pump
by: A.B.R. Thomson
Published: (1989-01-01) -
A Randomized Trial Comparing Seven-Day Ranitidine Bismuth Citrate and Clarithromycin Dual Therapy to Seven-Day Omeprazole, Clarithromycin and Amoxicillin Triple Therapy for the Eradication of Helicobacter pylori
by: Sander Veldhuyzen van Zanten, et al.
Published: (2003-01-01) -
Omeprazole for Refractory Gastroesophageal Reflux Disease during Pregnancy and Lactation
by: John K Marshall, et al.
Published: (1998-01-01)